Anixa Biosciences Inc

ANIX · Nasdaq · SIC 2834: Pharmaceutical Preparations
309
SEC Filings

Business Summary

PART I Overview Anixa Biosciences, Inc. is a biotechnology company developing therapies and vaccines that are focused on critical unmet needs in oncology. Our therapeutics program consists of the development of liraltagene autoleucel (lira-cel), a chimeric endocrine receptor-T cell therapy, which is a novel form of chimeric antigen receptor-T cell (CAR-T) technology, initially focused on treating ovarian cancer, that is being developed at our subsidiary, Certainty Therapeutics, Inc. (Certainty)....

Next Earnings

Q2 FY2026 — expected 2026-09-22

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionANIXdiscussed_in_filing Cybersecurity
topic_mentionANIXdiscussed_in_filing Trusted Computing
topic_mentionANIXdiscussed_in_filing Blockchain & Crypto
topic_mentionANIXdiscussed_in_filing Regulation
topic_mentionANIXdiscussed_in_filing Healthcare & Bio
topic_mentionANIXdiscussed_in_filing Platform & Ecosystem
topic_mentionANIXdiscussed_in_filing Sovereign & Government
topic_mentionANIXdiscussed_in_filing Cybersecurity
topic_mentionANIXdiscussed_in_filing Trusted Computing
topic_mentionANIXdiscussed_in_filing Blockchain & Crypto
topic_mentionANIXdiscussed_in_filing Regulation
topic_mentionANIXdiscussed_in_filing Healthcare & Bio
topic_mentionANIXdiscussed_in_filing Platform & Ecosystem
topic_mentionANIXdiscussed_in_filing Sovereign & Government
topic_mentionANIXdiscussed_in_filing Cybersecurity
topic_mentionANIXdiscussed_in_filing Trusted Computing
topic_mentionANIXdiscussed_in_filing Blockchain & Crypto
topic_mentionANIXdiscussed_in_filing Regulation
topic_mentionANIXdiscussed_in_filing Healthcare & Bio
topic_mentionANIXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-01-122025-10-310001493152-26-001845EDGAR40K words
2025-01-102024-10-310001493152-25-001787EDGAR—
2024-01-162023-10-310001493152-24-002453EDGAR—
2023-01-042022-10-310001493152-23-000346EDGAR—
2022-01-042021-10-310001493152-22-000302EDGAR—
2021-01-072020-10-310001493152-21-000456EDGAR—
2020-01-092019-10-310001513162-20-000009EDGAR—
2019-01-112018-10-310001513162-19-000016EDGAR—
2018-01-092017-10-310001513162-18-000006EDGAR—
2016-12-072016-10-310001513162-16-001096EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-092026-01-310001493152-26-009370EDGAR15K words
2025-09-102025-07-310001493152-25-013000EDGAR—
2025-05-282025-04-300001641172-25-012701EDGAR—
2025-03-112025-01-310001493152-25-009854EDGAR—
2024-09-062024-07-310001493152-24-035335EDGAR—
2024-06-042024-04-300001493152-24-022573EDGAR—
2024-03-122024-01-310001493152-24-009683EDGAR—
2023-09-062023-07-310001493152-23-031826EDGAR—
2023-06-142023-04-300001493152-23-021271EDGAR—
2023-03-172023-01-310001493152-23-007994EDGAR—
2022-09-092022-07-310001493152-22-025490EDGAR—
2022-06-102022-04-300001493152-22-016452EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001493152-26-009699EDGAR1K words
2026-02-090001493152-26-005702EDGAR—
2025-12-120001493152-25-027321EDGAR—
2025-03-210001493152-25-011151EDGAR—
2024-11-080001493152-24-044224EDGAR—
2024-05-080001493152-24-018170EDGAR—
2024-03-220001493152-24-010995EDGAR—
2023-12-070001493152-23-043932EDGAR—
2023-04-170001493152-23-012483EDGAR—
2023-03-100001493152-23-007172EDGAR—

309 total filings indexed. 277 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000715446
TickerANIX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3c3b0330df27e190d808e2fd9c361a830a99c68aa49e7d98d37900314aaf4248
parent: 61948c325acaa668319052ee33e43cf74615f8c8f50766863acd09120212dabd
content hash: eacc32be66b192268708e91432f5ba86ce7a13b109aca4a967bb83ff07888517
signed: 2026-04-13T04:43:39.526Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf